Involvementofmitochondriainapoptosisofcancer
cellsinducedbyphotodynamictherapy
Envolvimentodamitocôndriaemapoptosedecélulascancerígenasinduzidaporterapiafotodinâmica
JoselitoNardyRibeiro1;AndréRomerodaSilva1;RenatoAtilioJorge2
1.DoctorinScience,InstituteofChemistry,UniversidadeEstadualdeCampinas(UNICAMP),Campinas,SãoPaulo,Brazil. 2.ProfessorandDoctorinScience,InstituteofChemistry,UNICAMP.
resumo
Aterapiafotodinâmica(TFD)éumpromissortratamentoclínicoqueempregaacombinaçãodeluzvisível, oxigênioeumasubstânciafotossensibilizadoraparatratardoençasdecaráteroncológico.Essetipode tratamentoinduzamortecelularprogramada(apoptose)emtecidotumoral.Noentanto,omecanismode induçãodeapoptoseporTFDnãoestábemcaracterizado.Muitosfotossensibilizadorespossuemcomoalvo principalamitocôndria.OtratamentocomTFDcausadanosnessaorganelaeinduzaapoptoseatravésda liberaçãodecitocromoc,fatordeinduçãodeapoptose,Smac/DIABLOecertaspró-caspases.Aliberação dessasproteínas,apartirdamitocôndria,éreguladaporumafamíliadeproteínaspróeantiapoptóticas, conhecidacomofamíliaBCL-2.Apropostadessaminirrevisãoéapresentaralgumaspublicaçõesrecentes quefocalizamoenvolvimentodamitocôndriaemapoptosedecélulascancerígenasinduzidaporTFD.Terapiafotodinâmica
Apoptose
Mitocôndria unitermos
Primeirasubmissãoem03/04/03
Últimasubmissãoem31/07/03
Aceitoparapublicaçãoem02/09/03
Publicadoem15/06/04
JBrasPatolMedLab•v.40•n.6•p.383-90•dezembro2004 REVIEWARTICLE
Primeirasubmissãoem05/02/04
Últimasubmissãoem05/02/04
Aceitoparapublicaçãoem17/08/04
Publicadoem20/12/04
Introduction
Theseproteinsarecytochromec(cytc)(21),apoptosis
inducing factor (AIF)(28), and Smac/DIABLO(6), which
initiatedownstreamapoptoticsignalingevents.
Apoptosis
Programmed cell death (PCD) or apoptosis is a fundamental property of all multicellular organisms. ThePCD,agene-regulatedformofcelldeath,occursat differentstagesofgrowth,forexample,toeliminatecells betweendevelopingdigitsordegenerationofneurons In photodynamic therapy (PDT), visible light
activates a photosensitizing drug accumulated in tumororotherabnormaltissue(10,13,25).Theinteraction
between the excited photosensitizer and molecular oxygenproducessingletoxygen(1O
2)aswellasother
reactive oxygen species (ROS) to induce cancer cell death(2, 24, 42, 44, 49).ThemodeofcelldeathbyPDTis
often apoptosis, and substantial evidence supports the involvement of mitochondria in this process(32, 65-67). During apoptosis, mitochondria release soluble
proteinsfromtheintermembranespaceintocytosol.
abstract
Photodynamictherapy(PDT),apromisingcancertreatmentthatemploysacombinationofaphotosensitizing chemical,oxygen,andvisiblelight,inducesapoptosisintumorcells.However,theprecisemechanismof PDT-inducedapoptosisisnotwellcharacterized.Manyofthephotosensitizerscurrentlyinclinicalorpre-clinicalstudiesofPDTarelocalizedinorhaveamajorinfluenceonmitochondria.ThetreatmentwithPDT causesmitochondrialdamageandinducesapoptosisthroughthereleaseofcytochromec(cytc),apoptosis-inducingfactor(AIF),Smac/DIABLOandcertainprocaspases.Proapoptoticandantiapoptoticmembersof BcL-2familyregulatethereleaseoftheseproteinsfrommitochondria.Thepurposeofthismini-reviewisto presentsomerecentpublicationsthatfocusontheinvolvementofthemitochondriainapoptosisofcancer cellsinducedbyPDT.
Photodynamictherapy
Apoptosis
Mitochondria
y
thatfailtoformpropercellularconnections.Somecellsalso dieduringtheorganism’slifecycletoregulatethesizeof thecellpopulationintissues.Additionally,whencellsare confrontedwithenvironmentalstresses,theycaneitherbe destroyedaccidentallyorcanself-destructusinganactive mechanism(apoptosis).Thisdependsonthestresstypeor intensity(8).DisturbedPCDplaysamajorroleindiseases,
suchascancerandneurodegeneration(50).ExcessivePCD
canleadtodegenerativediseases(56),whereasinsufficient
apoptosiscanleadtocancer(18),becausetheorganismloses
controloftheproliferationofacellline(20).
Morphology of apoptosis
The hallmarks of apoptosis in animal cells include chromatincondensation,internucleosomalDNAcleavage, cellfragmentation,andformationofapoptoticbodies.These bodiesareremovedbyscavengingmacrophages(17).
DNAfragmentationinparticularhasbeenusedasan indication of apoptosis, and several simple assays have beenusedtoassesstheextentofDNAfragmentationin apoptoticcells.Forexample,agarosegelelectrophoresis(47)
isusedtodemonstratetheladderpaternofDNAwichis generatedbyendonucleolyticcleavageofgenomicDNA intonucleosomalsizeDNAofapproximately180baseslong (monomers)oroligonucleotides,whicharemultiplesof180 bases(oligomers)(69).
Mitochondrial apoptotic pathway
Mitochondriahaveemergedasthecentralprocessing organellesinthemajorityofapoptoticpathways.Signals from cell surface death receptors or from damaged sites converge on mitochondria, leading to permeabilization of both mitochondrial membranes, dissipation of the inner membrane transmembrane potential and release of several apoptosis-related proteins, normally located in the intermembrane space of mitochondria(34, 35, 53). Some
oftheseproteinsareAIF,Smac/DIABLO,cytc,andcertain procaspases.Thereleaseofapoptosis-relatedproteinsand collapseofthemitochondrialtransmembranepotentialresults fromtheopeningofalargeconductancechannelknownas the permeability transition pore complex (PTPC), which formsatcontactsitesoftheouterandinnermitochondrial membranes(46).Thisporeisformedbythetransientcomplex
ofthevoltage-dependentanionchannel(VDAC)onouter membrane,theadeninenucleotidetransporter(ANT)from theinnermembraneandcyclophilinDinthematrix.The
innermembraneisnormallyimpermeabletoanions,but when the PTPC pore forms, it is thought that the rapid movement of water causes this compartment to swell, rupturingtheoutermembrane(27,28,62).
AIF is localized in the mitochondria and released in responsetoPCDstimuli(28).Thisapoptosis-inducingfactor
movesdirectlytothenucleus,whereitproduceschromatin condensationandnuclearfragmentation(62).
Smac/DIABLOisarecentlyidentifiednovelproapoptotic molecule,whichisreleasedfrommitochondriaintocytosol duringapoptosis.Thismitochondrialproteinperformsa criticalfunctioninapoptosisbyeliminatingtheinhibitory effectsofIAPs(inhibitorofapoptosisproteins)(6).TheIAPs
potentlyinhibitthecatalyticactivityofcaspases(58).
Inapoptoticcellsthecytc,acomponentoftheelectron transportchainthatshuttleselectronsbetweencomplexesIII andIV(cytochromeoxidase),isreleasedfrommitochondria intocytosol,andinteractswithApaf-1andpro-caspase9 toformacomplex(apoptosome)(71).Thiscomplexcauses
acaspaseactivationcascadethatculminatesincelldeath characterizedbyapoptoticmorphology(39,41,73,74).
Thecytc releaseinapoptoticcellsisregulatedbyBCL-2 family proteins. The first apoptotic gene (BCL-2) was discoveredatthebeginningoftheninetiesandwasshown tobeasupressorofapoptosis(26).OthergenesoftheBCL-2
familyweresubsequentlyfoundonthebasisofsequence similaritiesandphysicalinteractions.Thisgenefamilyisnow composedofproapoptoticandantiapoptoticmembers(52).
Antiapoptoticmembersofthisfamily,includingBCL-2and BCL-XL,bindtothemitochondrialoutermembraneand blockAIF(64),smac/DIABLO(1,63),andcytcefflux(3).
TheproapoptoticmembersoftheBCL-2family,suchas BaxandBid,promotethereleaseofcytcandotherproteins ofthemitochondrialintermembranespace(3).Baxfunctions
directly on mitochondria to stimulate the release of cyt
cbyformingaselectiveporeintheoutermitochondrial membrane, whereas others argue that Bax interacts with VDAC and/or ANT to facilitate opening PTPC(14, 29, 57). Evidence indicates that Bid induces conformational
changeinBaxthatallowsthisproteintoinsertintheouter mitochondrialmembraneandstimulatecytcrelease(15).
byself-cleavage(46,62).Caspasesareoftenclassifiedasinitiator
(caspases2,8,9,10),andeffector(caspases3,6,7).Initiator caspases,suchascaspase8,activateeffectorcaspaseswhich in turn cleave and inactivate proteins that protect living cellsfromapoptosis,suchastheDNArepairprotein,poly (ADP-ribose) polymerase (PARP), ICAD/DFF45 (inhibitor of caspase-activated DNase, the nuclease responsible for DNA fragmentation), and antiapoptotic BCL-2 proteins. Otheractionsofcaspasesinapoptosisincludecleavageof cytoskeletalproteins,includingthelamins,proteinsforming thenuclearlamina;cytoplasmicintermediatefilaments,and several proteins involved in cytoskeletal regulation. This cleavageprovokesdisassemblyofcellstructuresthatdepend onthecytoskeleton(46).
Figure 1 demonstrates a summary of the apoptotic
mechanismmediatedbymitochondria:
Photodynamic therapy
Photodynamictherapyisconsideredtohaveitsorigins in1900withtheclassicexperimentsbyRaab.Heobserved that when paramecia were exposed to either sunlight aloneortothechemicalacridineinthedark,noeffects wereobserved.However,alethalreactionoccurredifthe microorganismswereexposedtoanacridinesolutionand sunlightconcurrently.Hedescribedthistoxiceffectasdose dependent,withrespecttobothacridineconcentrationand durationofexposuretosunlight(68).
Currently PDT is a clinical treatment that employs a combination of a photosensitizing compound, oxygen, and visible light for the therapy of several oncological, cardiovascular,dermatological,andophthalmicdiseases(38).
Figure1–Schematicrepresentationoftheprogrammedcelldeath(apoptosis) mediatedbymitochondria.MitochondrialROSproduction,PTPCformation,and swellingprovokereleaseofproapoptoticproteins(cytc,AIF,andSmac/DIABLO) intocytosol.TheseproteinsprovokecaspaseactivationresultinginPARPandlamin cleavage.ThiseventresultsintheDNAfragmentation
������������ �������������� ����� ��������� ���������
������� ����������������
���� �������� �������������
������ ���� ����
��� ����
������� �������
���
���������� �� ���� �� ������������������
�� �
� � ���
���� ������� ��� ����������
����
������������ �������������� ����� ��������� ���������
������� ����������������
���� �������� �������������
������ ���� ����
��� ����
������� �������
���
���������� �� ���� �� ������������������
�� �
� � ���
���� ������� ��� ����������
������������ �������������� �������������� ���������
������� ����������������
������������ �������������
������� ��� ����
��� ����
������� �������
���
���������� �� ���� �� ������������������
�� �
� � ���
����������� ������������� ����
������������� ������������
Figure2–Schematicoftumortherapyusingaphotosensitizingdrugandvisiblelightincidence
�����
���������������������� �����������������
����� �����������
������������� ������������������
����������������
Thistechniqueischaracterizedbysystemicadministration ofaphotosensitizingdrug,whichispreferentiallyretained bydiseasedtissue.Thephotodestructionofthetumoris performedaftervisiblelightincidence(5,45).Thetreatment
resultsintheproductionofROS,suchas1O
2andsuperoxide
radical(O2•-),thatprovokeasequenceofoxidativeevents
resultingincancercelldeathbyapoptosisand/ornecrosis(16, 31)andeventualtumorablation(Figure2)(5).
ThemechanismsofROSproductioncanbetypeI,type IIorboth.Thesuperoxideandotherradicalsspeciesare generatedwiththetypeImechanismbyelectrontransfer from photosensitizer, in the excited triplet state (T1), to ground-state oxygen (3O
2). Singlet oxygen is generated
with the type II mechanism by energy transfer from phtotosensitizerT1to3O
2(19,59)(Figure3).
Atpresent,onlyonephototherapeuticagent,namely Photofrin®, has been approved for clinical use in cancer
treatment(11).ThisdrughasbeenapprovedinCanadaforthe
prophylactictreatmentofbladdercancer.TheNetherlands, France, Germany, and Japan have approved it in cases ofearlyandadvancedstagesofcancerofthelung,the digestivetract,andthegenitourinarytract(9).IntheUnited
States of America, Photofrin® is the only photosensitizer
approved by FDA (Food and Drug Administration) for clinicaluseinpatientswithesophagealandlungcancer(37, 48). However Photofrin® suffers from some drawbacks(12).
Firstly,itisacomplexmixtureofseveralpartiallyunidentified porphyrinsanditshowsapoorselectivityintermsoftarget tissue/healthy tissue ratios. Secondly, its low extinction coefficients require the administration of relatively large amountstoobtainasatisfactoryphototherapeuticresponse. Furthermore,itpresentsahighaccumulationrateinskin, wichinducesaprolongedcutaneouslightultrasensibility lastingforupto6-8weeksafterPDTtreatment.Duringthis post-treatmentperiod,patientshavetostayoutofsunlight toavoidaseveresunburnreaction(51).
The problems encountered with Photofrin® have
encouragedthedevelopmentandthestudyofalternative photosensitizers,suchasHypericin,Foscan,NPe6,Lutecium Texaphyrin,PhtalocyaninePc4,andothers(46,55,61).
Mitochondrial apoptotic pathway
in photodynamic therapy
Many of the photosensitizers currently in clinical or pre-clinicalstudiesofPDTarelocalizedinorhaveamajor
Figure3–Mechanisms(typesIandII)ofROSgenerationbycombinationoflight, photosensitizer(P),andground-stateoxygen(3O
2).Ground-statephotosensitizer
(S0)isirradiatedwithvisiblelightgeneratingexcitedsingletstatephotosensitizer(S1).
S1canrelaxbacktoexcitedstatephotosensitizer(T1)generatingsuperoxideradical
(3O
2•-)(mechanismtypeI)and/orsingletoxygen(1O2)(mechanismtypeII)(60) ��
� ����
������ � �������������� �� �
����� ������
� � � �
�� ���
����� � � �� ������������
� �����������
������������ � � �� � � �
� � � �
�� ���
������������ ������������
��� � ��
Figure4–Reactionofsingletoxygenwithtryptophan
� �
� � � � � � � ��
� � �
��� ���
� � �� � �
� � � � �
�
� �
� � � � � �
� � � � � � � ��
� �
influenceonmitochondria,andPDTisastronginducerof apoptosisinmanysituations(46).Therearemanysimilarities
betweenthemechanismsbywhichmitochondriaregulate apoptosis and mechanisms by which PDT kills cancer cells. During PDT,1O
2 attacks mitochondrial proteins
andpossiblyalterstheiraminoacidstructures(Figure4), therebydisruptingtheproteinsfoldingconformation.This mayforcethemintootherconformationsthatdisrupttheir normalfunctioning(43).
Treatment with antioxidant inhibits cytcrelease, caspase 3 activation and PARP cleavage associated with PDTtherebysupportingthecontentionthatROSgenerated by PDT induces apoptosis in cancer cells(40). It has been
demonstrated also that1O
2, generated by irradiation of
rosebengalwithvisiblelight,inducesapoptosisinhuman promyelocyticleukemiaHL-60cells(72).ThePDT-treatment
using rose bengal as the photosensitizer induces also apoptosisinhumanepidermalcarcinomaA431cells,but thiseventcanbeinhibitedby1O
2scavengersandspecific
targetofPDT,andPDTdamagetoBCL-2contributesto efficientinductionofapoptosis(70).Ithasbeenobservedthat
PDTutilizingphotosensitizerphtalocianine-4(Pc-4)causes photodestruction of BcL-2 in mitochondria. This event inducesapoptosisincancercellsbutitcanbeprevented by singlet oxygen scavenger L-histidine. In this work photochemicaldamagewasnotobservedinproapoptotic proteinBax,theVDAC,ortheANT(componentsofPTPC inmitochondria)(70).
Formation of mitochondrial reactive oxygen species was detected within minutes when human epidermal carcinoma A431 cells were exposed to Pc 4 and 670-675nm light. This was followed by mitochondrial inner membrane permeabilization, depolarization, swelling, and cytc release to cytosol, resulting in apoptotic cell death(36).TheirradiationofmurineleukemiaL1210cells
in presence of three photosensitizers (CPO, SnET2, and
m-THPC), caused rapid decrease of the mitochondrial membrane potential, release of cytc into cytosol and activationofcaspase-3.Theseeffectswerefollowedbythe appearanceofanapoptoticmorphology.Inthistreatment BcL-2photodamagewasdetecteddirectlyafterirradiation but the proapoptotic protein Bax is not affected(30).
Apoptosiswasalsoinducedinsmoothmusclecellsbythe combinationofthephotosensitizerverteporfinandvisible light.AfterPDT,anincreaseinmitochondrialcytcandAIF levelsweredetectedinthecytosol.AIFtranslocatedfrom mitochondria to the nucleus during the progression of apoptosis. In addition, cytcrelease provoked activation ofmultiplecaspasesduringPDT(22).CleavageofPARPand
DNAfragmentationwereobservedintumorcellstreated with the photosensitizer Hypericin. These events were precededbycytcrelease,activationofinitiatorcaspase-8, 9,3,andApaf-1(4).
PDTprotocolsemployinglysosomalsensitizersinduce apoptosisviaamechanismthatcausescytcreleaseprior to loss of mitochondrial membrane potential. It was demonstrated that lysosomal photodamage initiates mitochondrial-mediated apoptosis in murine hepatoma 1c1c7 cells. In this work, fluorescence microscopy demonstratedthatthephotosensitizerNpe6waslocalized inthelysosomes.IrradiationofcellswithNpe6induced rapiddestructionoflysosomes,andsubsequentcleavage/ activation of proapoptotic Bid, pro-caspase-9 and 3. This activation was provoked by release proteases from lysosomes. The activation of Bid caused the decrease of mitochondrialmembranepotentialandcytcrelease.This workdemonstratedthatphotodamagedlysosomestrigger
themitochondrialapoptoticpathwaybyreleasingproteases thatactivateBid(54).
Photodynamic therapy using photosensitizer Pc-4 causes mitochondrial damage and induces apoptosis throughthereleaseofcytctothecytosol.Anotherprotein situated in the mitochondrial intermembrane space, Smac/DIABLO,isalsoreleasedtothecytosolinresponse to apoptotic stimuli and promotes caspase activation by binding IAP(67). Recently, a study was made of the
mechanismofcytotoxiceffectsof5-aminolevulinicacid-basedphotodynamictherapy(ALA-PDT)onthehuman promyelocyticleukemiacelllineHL60.Thedecreaseof mitochondrialmembranepotentialwasaccompaniedbya decreaseintheATPlevel,releaseofcytcintocytosol,the activationofcaspases9and3,andthecleavageofPARP followedbyDNAfragmentation.Thesedatasuggestthat ALA-PDTactivatesthemitochondrialapoptoticpathway incancercells(23).
Inthescreeningofthenewanticanceragentsforusein PDT,itwasdiscoveredthatamethanolextractofbamboo leavesinducedrapidapoptosisinthehumanleukemiaCMK-7cellline.Thisapoptosiswasevaluatedbymonitoringthe caspase3activationandDNAcleavage(33).ATX-S10(Na),
a novel hydrophilic chlorin photosensitizer, shows good accumulation in tumors and is suitable for use in PDT. Recently,themechanismofPDT-induceddeathusingATX-S10(Na)anddiodelaserinnormalhumankeratinocytes (NHK)wasinvestigated.ATX-S10(Na)-PDThadinduced apoptosisofNHKintwohoursandthemaximaleffectwas observedaftersixhoursfollowingirradiation.Theeffect was supressed by pretreatment of NHK with inhibitors ofcaspases3,6,8and9,andwesternblottingrevealed cytosolicreleaseofcytcandAIF(65).
Conclusion
Acknowledgements
Figure5–Apoptosisinphotodynamictherapywithparticipationofmitochondria ���������������
������������
�������������� �������������������� ����� ���������
���� ������������������� ������� ������������������
���� �
��������� ��������������
����������� � ��������������
�������������������� ����� ��������� ���� ������������ ������������������ �����������������
�
��������� ��������������
����������� � ��������������
����������� ���
�
Brasília, and the Coordenação de Aperfeiçoamento de PessoaldeNívelSuperior(CAPES),Brasília.Wealsothank GydaMayforlanguageassistance.
References
1.ADRIAN,C.etal.Apoptosis-associatedreleaseofSmac/DIABLO
frommitochondriarequiresactivecaspasesandisblocked
byBcl-2.EmboJ,v.20,n.23,p.6627-36,2001.
2.AGARWAL, M. L. et al. Photodynamic therapy induces rapid cell-deathbyapoptosisinl5178ymouselymphoma-cells.
CancerRes,v.51,p.5993-6,1991.
3.AHSEN,V.O.etal.Preservationofmitochondrialstructureand
functionafterBid-orBax-mediatedcytochromecrelease.
JCellBiol,v.150,n.5,p.1027-36,2000.
4.ALI, S. M. et al. Hypericin induced death receptor-mediated
apoptosisinphotoactivatedtumorcells.IntJMolMed,v.9,
n.6,p.601-16,2002.
5. BONNETT, R. Photosensitizers of the porphyrin and
phthalocyaninesseriesforphotodynamictherapy.Chemical
SocietyReviews,v.24,p.19-33,1995.
6.CHAI,J.J.etal.Structuralandbiochemicalbasisofapoptotic
activationbySmac/Diablo.Nature
,v.406,n.6798,p.855-62,2000.
7.CHAN,W.H.etal.Apoptoticsignallingcascadeinphotosensitized human epidermal carcinomaA431 cells: involvement of
singletoxygen,c-JunN-terminalkinase,caspase-3andp21-activatedkinase2.BiochemJ,v.351,p.221-32,2000.
8.DANON,A.etal.Plantprogrammedcelldeath:acommonway
todie.PlantPhysiolBiochem,v.38,p.647-55,2000.
9.DOUGHERTY,T.J.etal.Photodynamictherapy(review).JNatl
CancerInst,v.90,p.889-905,1998.
10. DOUGHERTY,T. J.An update on photodynamic therapy applications.JClinLaserMedSur,v.20,p.3-7,2002.
11.DOUGHERTY,T.J.Photodynamictherapy:basicprinciplesand
clinicalapplication.NewYork:MarcelDekker,1992.
12. DOUGHERTY,T. J. Photosensitizers, therapy and detection
ofmalignanttumors.PhotochemPhotobiol,v.45,p.879-89,
1987.
13.DOUGHERTY,T.J.;MARCUS,S.L.Photodynamictherapy.EurJ
Cancer,v.28,p.1734-42,1992.
14. ESKES, R. et al. Bax-induced cytochrome C release from mitochondriaisindependentofthepermeabilitytransition
porebuthighlydependentonMg2+ions.JCellBiol,v.143,
p.217-24,1998.
15.ESKES,R.etal.Bidinducestheoligomerizationandinsertionof
Baxintotheoutermitochondrialmembrane.MolCellBiol,
v.20,p.929-35,2000.
16.FABRIS,C.etal.Photosensitizationwithzinc(ΙΙ)phtalocyanine
asswitchinthedecisionbetweenapoptosisandnecrosis.
CancerRes,v.61,n.20,p.7495-500,2001.
17. FATH,A. et al.Barley aleurone cell death is not apoptotic: characterizationofnucleaseactivitiesandDNAfragmentation. ThePlantJournal,v.20,n.3,p.305-15,1999.
18.FICHER,D.E.Apoptosisincancertherapy:crossingthethreshold. Cell,v.78,p.539-42,1994.
19.FOOTE,C.S.DefinitionoftypeIandtypeIIphotosensitized
oxidation.PhotochemPhotobiol,v.54,n.5,p.659,1991.
20. GILCHRIST, D. G. Programmed cell death in plant disease:
the purpose and promise of cellular suicide.Annu Rev
Phytophatol,v.36,p.393-414,1998.
21.GOGVADZE,V.etal.CytochromecreleaseoccursviaCa2+
-dependent and Ca2+-independent mechanisms that are
regulated by Bax.J Biol Chem, v. 276, n. 22, p. 19066-71, 2001.
22. GRANVILLE, D. J. et al.Mitochondrial release of
apoptosis-inducingfactorandcytochromecduringsmooth
musclecellapoptosis.AmericanJPathol
,v.159,n.1,p.305-11,2001.
23. GREBENOVA, D. et al. Mitochondrial and endoplasmatic reticulumstress-inducedapoptoticpathwayareacrivated by 5-aminolevulinic acid-based photodynamic therapy in
HL60leukemiacells.JPhotochemPhotobiolB-Biology,v.69, n.2,p.71-85,2003.
24.HE,X.Y.etal.Photodynamictherapywithphotofrin-iiinduces
programmedcell-deathincarcinomacell-lines.Photochem
Photobiol,v.59,p.468-73,1994.
25. HENDERSON, B.W.; DOUGHERTY,T. J. How does
photodynamictherapywork.PhotochemPhotobiol,v.55,p.
145-57,1992.
26.HOCKENBERGY,D.M.etal.Bcl-2isaninnermitochondrial membrane protein that blocks programmed cell death.
Nature,v.348,p.334-6,1990.
27.JONES,A.Doestheplantmitochondriaintegratecellularstress
andregulateprogrammedcelldeath?TrendsinPlantSciPersp,
v.5,n.5,p.225-30,2000.
28.JOZA,N.etal.
Essentialroleofthemitochondrialapoptosis-inducingfactorinprogrammedcelldeath.Nature,v.410,p.
549-54,2001.
29. JURGENSMEIER, J. M. et al.Bax directly induces release of
cytochromecfromisolatedmitochondria.ProcNatlAcad
SciUSA,v.95,p.4997-5002,1998.
30.KESSEL,D.;CASTELLI,M.EvidencethatBcl-2isthetargetof threephotosensitizersthatinducerapidapoptoticresponse.
PhotochemPhotobiol,v.74,n.2,p.318-22,2001.
31. KESSEL, D.; LUO,Y. Photodynamic therapy: a mitochondrial
inducerofapoptosis.CellDeathDiffer,v.6,n.1,p.28-35,
1999.
32.KESSEL,D.;REINERSJr.,J.J.Apoptoticresponsetophotodynamic
therapyversus the Bcl-2Antagonist HA14-1.Photochem
Photobiol,v.76,n.3,p.314-9,2002.
33.KIM,K.K.etal.Anovelporphyrinphotosensitizerfrombamboo
leavesthatinducesapoptosisincancercelllines.Anticancer
Res,v.23,n.3B,p.2355-631,2003.
34.KROEMER,G.etal.Themitochondrialdeath/liferegulatorin
apoptosisandnecrosis.AnnuRevPhysiol,v.60,p.619-42,
1998.
35.KROEMER,G.;REED,J.C.Mitochondrialcontrolofcelldeath.
NatMed,v.6,p.513-9,2000.
36. LAM, M. et al. Photodynamic therapy-induced apoptosis in
epidermoidcarcinomacells.JBiolChem
,v.276,p.47379-86,2001.
37.LASERMEDICALRESEARCHFOUNDATION.Availableat: [http://209.41.253.5:80/pdt@lmrf].Accessed on: January 10,2003.
38.LEVY,J.G.;OBOCHI,M.Newapplicationsinphotodynamic
therapyintroduction.PhotochemPhotobiol,v.64,p.737-9,
1996.
39.LI,P.etal.CytochromecanddATP-dependentformationof
Apaf-1/caspase-9complexinitiatesanapoptoticportease cascade.Cell,v.91,p.479-89,1997.
40.LI,R.etal.Rapidinductionofapoptosisinhumankeratinocytes withthephotosensitizerQLT0074viaadirectmitochondrial action.Apoptosis,v.8,n.3,p.269-75,2003.
41.LIU,X.etal.Inductionofapoptoticprogramincell-freeextracts:
requirementfordATPandcytochromec.Cell
,v.86,p.147-57,1996.
42.LUO,Y.etal.Rapidinitiationofapoptosisbyphotodynamic
therapy.PhotochemPhotobiol,v.63,p.528-34,1996.
43. MacDONALD, I. J.; DOUGHERTY,T. J. Basic principles of
photodynamictherapy.JPorphyrinsandPhthalocyanines,v.
5,p.105-29,2001.
44.MOAN,J.;BERG,K.Photochemotherapyofcancer-experimental
research.PhotochemPhotobiol,v.55,p.931-48,1992.
45.MOOR,A.C.E.Signalingpathwaysincelldeathandsurvival
afterphotodynamictherapy.JPhotochemPhotobiolB:Biol,
v.57,p.1-13,2000.
46. NANCY, L. et al.The role of apoptosis in response to photodynamic therapy: what, where, why, and how.
PhotochemPhotobiolSci,v.1,p.1-21,2002.
47.NARENDRA,P.S.Asimplemethodforaccurateestimation of apoptotic cells.Experiment Cell Res, v. 256, p. 328-37, 2000.
48. NATIONAL C ANCER INSTITUTE. Available at: [http://cancernet.nci.nih.gov].Accessed on: January 12, 2003.
49. OLEINICK, N. L.; EVANS, H. H.The photobiology of
photodynamic therapy: cellular targets and mechanisms.
RadiatRes,v.150,S146-S156,1998.
50.PETIT,P.X.etal.Mitochondrialandprogrammedcelldeath:back
tothefuture.FEBSLett,v.396,p.7-13,1996.
51.RAZUM,N.etal.Skinsphotosensitivity:durationandintensity
following intravenous hematoporphyrin derivatives, HPD
andDHE.PhotochemPhotobiol,v.46,p.925-8,1987.
52.REED,J.C.DoubleidentityforproteinsoftheBcl-2family.Nature, v.387,p.773-6,1997.
53. REED, J. C. Mechanisms of apoptosis.Am J Pathol, v. 157, p. 1415-30,2000.
54.REINERS,J.J.etal.Releaseofcytochromecandactivationof
pro-caspase-9followinglysosomalphotodamageinvolves Bidcleavage.CellDeathDiffer,v.9,n.9,p.934-44,2002.
55.RIBEIRO,J.N.etal.Photooxidationofbiomoleculesinpresence
ofoctaethylporphyrinandvanadyloctaethylporphyrin.XXXII
ReuniãoAnual da Sociedade Brasileira de Bioquímica e BiologiaMolecular.Caxambu-MG,2003.
56.SAVILL,J.Apoptosisanddisease.EurJClinInvest
,v.24,p.715-23,1994.
57.SHIMIZU,S.etal.Bcl-2familyproteinsregulatethereleaseof
apoptogeniccytochromecbythemitochondrialchannel
VDAC.Nature,v.399,p.483-7,1999.
58.SHIOZAKI,E.N.etal.MechanismofXIAP-mediatedinhibition
ofcaspase-9.MolecularCell,v.11,n.2,p.519-27,2003.
59.SIBATA,C.H.etal.Photodynamictherapy:anewconceptin
medicaltreatment.BrazilianJMedBiolRes,v.33,p.869-80,
2000.
60.SILVA,A.R.AnálisedaspropriedadesfotossensibilizantesdoIn
(III)-mesotetrafenilporfirinaparausoemterapiafotodinâmica. Campinas-SP,2003.Tese(mestrado)–InstitutodeQuímica, UNICAMP.
61. SILVA,A. R.; JORGE, R.A.Interactions studies of In
(III)-mesotetraphenylporphyrinwithunilamelarlipidicvesiclesand
photoxidation mechanism of human erythrocytes. XXXII
ReuniãoAnual da Sociedade Brasileira de Bioquímica e BiologiaMolecular.Caxambu-MG,2003.
63. SUN, X. M. et al. Bcl-2 and Bcl-x(L) inhibit CD95-mediated apoptosis by preventing mitochondrial release of Smac/
DIABLOandsubsequentinactivationofX-linkedinhibitor-of-apoptosisprotein.JBiolChem,v.277,n.13,p.11345-51,
2002.
64.SUSIN,S.A.etal.Bcl-2inhibitsthemitochondrialreleaseofan
apoptogenicprotease.JExpMed,v.184,n.4,p.1331-41,
1996.
65.TAKAHASHI, H. et al.Activation of two caspase cascades, caspase 8/3/6 and caspase 9/3/6, during photodynamic therapy using a novel photosensitizer,ATX-S10(Na), in
normalhumankeratinocytes.ArchDermatolRes,v.295,n.
6,p.242-8,2003.
66. USUDA, J. et al.Association between the photodynamic
loss of Bcl-2 and the sensitivity to apoptosis caused by
phthalocyaninephotodynamictherapy.PhotochemPhotobiol,
v.78,n.1,p.1-8,2003.
67.USUDA,J.etal.Promotionofphotodynamictherapy-induced apoptosis by mitochondrial protein Smac/DIABLO:
dependence on Bax.Photochem Photobiol, v. 76, n. 2, p.
217-23,2002.
68.VIA,D.L.;MAGNO,S.M.Photochemotherapyinthetreatment
ofcancer.CurrMedChem,v.8,p.1405-18,2001.
69.WYLLIE,A.H.etal.Celldeath:thesignificanceofapoptosis.Int
RevCytol,v.68,p.251-306,1980.
70. XUE, L.Y. et al.Photochemical destruction of the Bcl-2
oncoprotein during photodynamic therapy with the
phtalocyaninephotosensitizerPc4.Oncogene,v.20,n.26,
p.3420-7,2001.
71.YANG, J. et al. Prevention of apoptosis by Bcl-2: Release of
cytochromecfrommitochondriablocked.Science,v.275,
p.1129-32,1997.
72.ZHUANG,S.G.etal.Caspase-8mediatescaspase-3activation
and cytochromecrelease during singlet-oxygen-induced
apoptosisofHL-60cells.ExperimentCellRes,v.250,n.1,
p.203-12,1999.
73.ZOU,H.etal.AnApaf-1cytochromecmultimericcomplexis
afunctionalapoptosomethatactivatesprocaspase-9.JBiol
Chem,v.274,p.11549-56,1999.
74.ZOU,H.etal.Apaf-1,ahumanproteinhomologoustoC.elegans
CED-4,participatesincytochromec-dependentactivation
ofcaspase.Cell,v.90,p.405-13,1997.
Mailingaddress RenatoAtílioJorge
InstitutodeQuímicadaUniversidadeEstadual deCampinas(UNICAMP)
CidadeUniversitáriaZeferinoVaz,BarãoGeraldo Caixapostal6154